Neurodevelopmental outcomes in children and adults with Fetal Valproate Spectrum Disorder: A contribution from the ConcePTION project
- M Bluett-Duncan
- , D Astill
- , R Charbak
- , J Clayton-Smith
- , S Cole
- , P A Cook
- , J Cozens
- , K Keely
- , J Morris
- , R Mukherjee
- , E Murphy
- , P Turnpenny
- , J Williams
- , A G Wood
- , L M Yates
- , R L Bromley
- Division of Neuroscience, School of Biological Sciences, The University of Manchester, UK. Electronic address: [email protected].
- Foetal Anti-Convulsant Syndrome New Zealand, Aukland, New Zealand.
- Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
- Division of Evolution, Systems and Genomics, University of Manchester, UK.
- Pharma Consent, London, UK.
- School of Health and Society, University of Salford, UK.
- Organisation for Anti-Convulsant Syndrome, UK.
- Organisation for Anti-Convulsant Syndrome, Ireland.
- Department of Health and Social Science, University of Salford, Allerton Building, Salford, England, UK.
- Independent Fetal Anti-Convulsant Trust, Preston, UK.
- Royal Devon and Exeter NHS Foundation Trust
- Northern Genetics Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, UK; KRISP, University of KwaZulu-Natal, South Africa.
- Division of Neuroscience, School of Biological Sciences, The University of Manchester, UK; Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Research output: Contribution to journal › Article › peer-review
9
Link opens in a new tab
Citations
(Scopus)
13
Downloads
(Pure)